Karyopharm Therapeutics Inc.
KPTI
$7.46
$1.1518.23%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -26.08% | -35.66% | -18.58% | -12.23% | 2.39% |
| Total Receivables | -6.56% | 14.55% | -3.18% | -17.66% | 24.17% |
| Inventory | 4.68% | 0.63% | 1.43% | 34.41% | 25.53% |
| Prepaid Expenses | -19.80% | -16.01% | -16.96% | 3.03% | -7.53% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -9.09% | 3.13% | -93.03% |
| Total Current Assets | -18.60% | -23.17% | -15.30% | -11.41% | 5.13% |
|
|
|||||
| Total Current Assets | -18.60% | -23.17% | -15.30% | -11.41% | 5.13% |
| Net Property, Plant & Equipment | -8.17% | -7.72% | 103.96% | -18.90% | -14.71% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.60% | 1.95% | 0.12% | 0.12% | 0.00% |
| Total Assets | -17.88% | -22.33% | -13.22% | -11.45% | 4.66% |
|
|
|||||
| Total Accounts Payable | -55.77% | 14.98% | -11.69% | 106.76% | -44.37% |
| Total Accrued Expenses | 10.07% | -5.74% | 21.05% | 0.59% | -9.19% |
| Short-term Debt | 0.10% | 0.14% | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 723.41% | 111.64% | -88.06% | 3.47% | 3.50% |
| Total Finance Division Other Current Liabilities | -18.92% | 18.22% | -15.28% | 31.95% | -27.93% |
| Total Other Current Liabilities | -18.92% | 18.22% | -15.28% | 31.95% | -27.93% |
| Total Current Liabilities | 9.79% | -2.05% | 50.04% | 6.72% | -11.82% |
|
|
|||||
| Total Current Liabilities | 9.79% | -2.05% | 50.04% | 6.72% | -11.82% |
| Long-Term Debt | -1.13% | -3.43% | -10.47% | -0.20% | -12.84% |
| Short-term Debt | 0.10% | 0.14% | -- | -- | -- |
| Capital Leases | -3.61% | -3.38% | -- | -- | -49.31% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 49.71% | -43.98% | -36.22% | 2.73% | 787.41% |
| Total Liabilities | 3.06% | -4.81% | 0.38% | 0.87% | -7.31% |
|
|
|||||
| Common Stock & APIC | 0.30% | 0.26% | 0.33% | 0.31% | 0.97% |
| Retained Earnings | -2.35% | -1.50% | -2.01% | -2.14% | 1.56% |
| Treasury Stock & Other | 21.81% | 9.83% | -60.36% | 63.31% | -16.80% |
| Total Common Equity | -16.05% | -10.68% | -16.52% | -20.82% | 21.79% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -16.05% | -10.68% | -16.52% | -20.82% | 21.79% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -16.05% | -10.68% | -16.52% | -20.82% | 21.79% |
|
|
|||||